Skip to main content
FEEDBACK PLC logo

FEEDBACK PLC — Investor Relations & Filings

Ticker · FDBK ISIN · GB00BJN59X09 LEI · 213800UGOF2GT2U2RV90 IL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 326 across all filing types
Latest filing 2015-06-03 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL FDBK

About FEEDBACK PLC

https://fbkmed.com/

Feedback PLC is a medical technology company specializing in clinical infrastructure software designed to improve healthcare communication and workflows. Its flagship product, Bleepa®, is a secure digital platform that enables asynchronous collaboration among clinicians. Bleepa provides a unified, patient-centric view of clinical data, including diagnostic-quality medical imaging, test results, and case notes. The platform facilitates secure messaging and virtual discussions for individuals and multi-disciplinary teams (MDTs), allowing for faster decision-making and streamlined referral pathways. By enabling remote and asynchronous case reviews, Bleepa aims to improve care coordination, reduce outpatient appointment requirements, and shorten patient treatment times across public and private healthcare settings.

Recent filings

Filing Released Lang Actions
Issue of Equity
Share Issue/Capital Change Classification · 1% confidence The document is identified by the 'RNS Number' header and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content explicitly announces the 'Issue of Equity' through a 'Placing' of new ordinary shares, including participation by directors, which is a form of capital/financing activity. This type of announcement, distributed via the Regulatory News Service (RNS), fits best under the 'Share Issue/Capital Change' (SHA) category, as it details the issuance of new shares and the resulting change in capital structure. While it is an RNS filing, SHA is more specific to the core subject matter than the general RNS fallback.
2015-06-03 English
Preliminary results from the Oxford Stone Group
Legal Proceedings Report Classification · 1% confidence The document is identified by the 'RNS Number : 8097M' header and the concluding statement 'This information is provided by RNS The company news service from the London Stock Exchange'. This indicates it is a regulatory announcement made via the Regulatory News Service (RNS). The content details preliminary research results concerning a medical imaging software (TexRAD) and its application in predicting kidney stone treatment success. This type of announcement, which is a specific operational/research update that doesn't fit neatly into standard financial reports (10-K, ER, IR) or corporate actions (DIV, CAP), is best classified under the general regulatory announcement category. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general, time-sensitive regulatory news service release that is not a core financial report or specific corporate action notice.
2015-05-11 English
Drug Trial and Trading Update
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 5975L' and concludes with 'This information is provided by RNS The company news service from the London Stock Exchange'. This strongly indicates it is a regulatory announcement disseminated via the London Stock Exchange's Regulatory News Service (RNS). The content itself is a combination of a drug trial update and a trading update (revenue/loss expectations), which are typical subjects for RNS announcements. Since 'RNS' is the specific service used for dissemination and the content is a general operational/trading update that doesn't fit perfectly into ER (Earnings Release - usually quarterly/periodical results) or CAP (Financing Update), the most appropriate classification based on the delivery mechanism and general nature is Regulatory Filings (RNS). The document length is short (2217 chars), suggesting it is an announcement rather than a full report.
2015-04-29 English
First sale of TexRAD in South Korea
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated April 27, 2015. It announces a specific business event: 'First sale of TexRAD in South Korea' by Feedback plc. This is a typical structure for a regulatory news service announcement detailing a commercial development, contract win, or operational update that is material to investors. It is not a full financial report (10-K, IR), a transcript (CT), or a management presentation (IP). Since it is a general, material announcement disseminated via the RNS system and doesn't fit the highly specific categories like Director's Dealing (DIRS) or Dividend Notice (DIV), the most appropriate classification is the general regulatory announcement category.
2015-04-27 English
Stmnt re Share Price Movement
Share Issue/Capital Change Classification · 1% confidence The document is very short (1285 characters) and contains an RNS Number ('1302L') and the header 'RNS Number'. It is a brief statement from Feedback plc noting a share price movement and stating they are unaware of a specific reason, while also mentioning ongoing customer discussions. This type of short, immediate market disclosure that doesn't fit a specific financial report category (like 10-K, ER, or IR) and is distributed via the London Stock Exchange's news service (RNS) is best classified as a general Regulatory Filing or announcement. Since 'RNS' is explicitly mentioned as the source/service, and it's a general market update, the most appropriate code is RNS, which serves as the miscellaneous regulatory filing fallback.
2015-04-23 English
Adoption of TexRAD research software
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated 20 April 2015. It announces specific business developments, namely the adoption of the company's TexRAD research software by four new institutions across Germany, Wales, Japan, and France. This type of announcement, detailing operational updates, sales milestones, or general corporate news released via the Regulatory News Service (RNS) system, fits best under the general regulatory announcement category. Since it is not a formal financial report (10-K, IR, ER), a specific management change (MANG), or a director's dealing (DIRS), the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such announcements released through the LSE's news service.
2015-04-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.